Daniela M. Ferreira

Liverpool School of Tropical Medicine - Department of Clinical Sciences

Liverpool

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS
Rank 380

SSRN RANKINGS

Top 380

in Total Papers Downloads

52,987

SSRN CITATIONS

2

CROSSREF CITATIONS

1

Scholarly Papers (3)

1.

Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

Number of pages: 37 Posted: 01 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Siena - Institute of Global Health, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, Federal University of Sao Paulo, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, University of the Witwatersrand, Soweto Clinical Trials Centre, Soweto Clinical Trials Centre, University of Oxford - Oxford Vaccine Group, Setshaba Research Centre, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Cape Town - Centre for Lung Infection and Immunology, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, University of Oxford - Jenner Institute, Wits Reproductive Health & HIV Institute (WRHI), University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Oxford - Oxford Vaccine Group, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University Hospitals Bristol and Weston NHS Foundation Trust, University of London - St George's Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - South African Medical Research Council, Liverpool School of Tropical Medicine - Department of Clinical Sciences, AstraZeneca Pharmaceuticals, University of the Witwatersrand - South African Medical Research Council, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - South African Medical Research Council, University of the Witwatersrand - South African Medical Research Council, North Bristol NHS Trust - Severn Pathology, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, University of Oxford - Oxford Vaccine Group, AstraZeneca Pharmaceuticals, Braziland Hospital São Rafael - Escola Bahiana de Medicina e Saúde Pública, Universidade Federal do Rio Grande do Norte (UFRN), University of Oxford - Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - Perinatal HIV Research Unit, Setshaba Research Centre, University of Oxford - Oxford Vaccine Group, Hospital Quinta D'OR, University of Oxford - Oxford Vaccine Group, NIHR Imperial Clinical Research Facility, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Federal University of Santa Maria (UFSM) - Clinical Research Unit, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Universidade Federal do Rio Grande do Sul, Western General Hospital - Clinical Infection Research Group, Queen Elizabeth University Hospital, University of Cambridge - Department of Medicine, Royal Papworth Hospital - Heart Lung Research Institute, University of Nottingham, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Jenner Institute, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group and affiliation not provided to SSRN
Downloads 44,690 (36)
Citation 3

Abstract:

Loading...

2.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

Number of pages: 40 Posted: 04 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Oxford - Big Data Institute, University of Oxford - Oxford Vaccine Group, University of Cambridge, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, University of Cambridge, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Jenner Institute, Public Health England - National Infection Service, University of Oxford - Oxford Vaccine Group, Liverpool School of Tropical Medicine - Department of Clinical Sciences, UK Biocentre, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - Jenner Institute, University of Oxford - Jenner Institute, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Oxford - Oxford Vaccine Group, University Hospitals Bristol and Weston NHS Foundation Trust, University of Oxford - Jenner Institute, University of Oxford - Jenner Institute, University of London - St George's Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, Public Health England - National Infection Service, University of London - St George's Vaccine Institute, Queen Elizabeth University Hospital, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, North Bristol NHS Trust - Severn Pathology, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, University of Cambridge, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, NIHR Imperial Clinical Research Facility, University of Oxford - Oxford Vaccine Group, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Western General Hospital - Clinical Infection Research Group, Queen Elizabeth University Hospital, Royal Papworth Hospital - Heart Lung Research Institute, University of Nottingham, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Jenner Institute, University of Oxford - Jenner Institute, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 8,283 (799)
Citation 5

Abstract:

Loading...

3.

Household Air Pollution (HAP) is Associated With Increased Pneumococcal Carriage in Malawian Infants – Malawi  Streptococcus pneumoniae Carriage and Air Pollution Exposure (MSCAPE) Study

Number of pages: 19 Posted: 19 Mar 2021
University of Liverpool, University of Liverpool - Department of Public Health and Policy, Malawi Epidemiology and Intervention Research Unit (MEIRU), University of Liverpool, Research Triangle Institute (RTI) International, University of Malawi - College of Medicine, Malawi Epidemiology and Intervention Research Unit (MEIRU), Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, BUGS Biosciences, Liverpool School of Tropical Medicine - Department of Clinical Sciences, Liverpool School of Tropical Medicine, University of Liverpool and University of Liverpool
Downloads 14 (651,119)

Abstract:

Loading...